TransUnion announced the closing of its previously announced secondary offering of 25,875,000 common shares by certain shareholders on Aug. 4.
The offering included an additional 3,375,000 common shares sold under the underwriters' 30-day option at a price of $45.60 each. No shares were sold by the company.
As a result of the offering, the number of shares owned by Advent International Corp. fell below a previously agreed upon threshold from a June 2015 agreement entitling the investor group to appoint a director.
However, the board waived the requirement and expects Advent's designated director Christopher Egan to serve his full term until May 2018.